Copyright
©The Author(s) 2015.
World J Diabetes. Apr 15, 2015; 6(3): 445-455
Published online Apr 15, 2015. doi: 10.4239/wjd.v6.i3.445
Published online Apr 15, 2015. doi: 10.4239/wjd.v6.i3.445
Table 3 Management strategies for new-onset diabetes after transplantation
Prevention strategies | Management strategies |
Identification of risk factors (Table 1) with pre-transplant counseling | Regular blood glucose monitoring with appropriate follow-up |
Pre- and post-transplant screening: random blood glucose, fasting blood glucose, 2-h oral glucose tolerance test with appropriate follow-up | Multi-disciplinary care |
Lifestyle modification: weight control, diet, exercise (subject to dialysis-imposed restrictions) | Lifestyle modification: weight control, diet, exercise |
Rapid corticosteroid reduction or avoidance | Rapid corticosteroid reduction |
Selective calcineurin-inhibitor use (e.g., cyclosporine instead of tacrolimus) | Conversion of cyclosporine to tacrolimus |
? Newer immunosuppressive agents (e.g., alemtuzumab, belatacept) | Oral hypoglycemic agents: metformin, sulfonylureas, meglitinides, dipeptidyl peptidase-4 antagonists (alone and/or in combination) |
? Magnesium oxide | Insulin |
? Statins | Monitoring for complications |
- Citation: Palepu S, Prasad GVR. New-onset diabetes mellitus after kidney transplantation: Current status and future directions. World J Diabetes 2015; 6(3): 445-455
- URL: https://www.wjgnet.com/1948-9358/full/v6/i3/445.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i3.445